Disposition kinetics of enrofloxacin (Baytril 5%) in sheep and goats following intravenous and intramuscular injection using a microbiological assay
- PMID: 12204629
- DOI: 10.1016/s0034-5288(02)00020-6
Disposition kinetics of enrofloxacin (Baytril 5%) in sheep and goats following intravenous and intramuscular injection using a microbiological assay
Abstract
The pharmacokinetics of enrofloxacin were determined in Desert sheep and Nubian goats after intravenous and intramuscular administration of Baytril at the dose of 5mgkg(-1) bodyweight. A two compartment open model best represented the intravenous plasma concentration versus time data in both species. Comparisons between the means of the pharmacokinetic parameters obtained after intravenous administration of enrofloxacin (Baytril) revealed a significantly smaller distribution rate constant (lambda(1)) and consequently a shorter half-life time of distribution in sheep (P<0.05). A larger volume of the central compartment (Vc) was observed in goats (P<0.05). Similar values were obtained for sheep and goats for the remaining parameters. Plasma concentrations versus time data of enrofloxacin after 5mgkg(-1) intramuscular administration of Baytril in sheep and goats were adequately described by one-compartment open model with first order absorption and elimination. There were no significant differences between sheep and goats in any of the estimated pharmacokinetic parameters. The results indicate that the pharmacokinetics of enrofloxacin did not differ significantly between sheep and goats; similar intravenous and intramuscular dose rates of enrofloxacin should therefore be applicable to both species. Owing to the high variations in MIC (minimal inhibitory concentration) of sensitive veterinary pathogens, it is recommended that enrofloxacin dosage regimens be calculated according to the sensitivity of the individual pathogen, site of infection and clinical response, than by following a preset dosage regimen.
Similar articles
-
Pharmacokinetics of enrofloxacin after intravenous and intramuscular administration in Angora goats.Can J Vet Res. 2001 Jan;65(1):64-7. Can J Vet Res. 2001. PMID: 11227198 Free PMC article.
-
Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and intramuscular administrations in sheep.Am J Vet Res. 1996 Jul;57(7):1040-3. Am J Vet Res. 1996. PMID: 8807018
-
Pharmacokinetic disposition of subcutaneously administered enrofloxacin in goats.Vet Res Commun. 2002 Oct;26(7):563-9. doi: 10.1023/a:1020295632767. Vet Res Commun. 2002. PMID: 12416871 Clinical Trial.
-
Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin in goats given enrofloxacin alone and in combination with probenecid.Vet J. 2002 Jan;163(1):85-93. doi: 10.1053/tvjl.2001.0594. Vet J. 2002. PMID: 11749141
-
Disposition of single-dose oral enrofloxacin in the horse.J Vet Pharmacol Ther. 1996 Aug;19(4):316-9. doi: 10.1111/j.1365-2885.1996.tb00057.x. J Vet Pharmacol Ther. 1996. PMID: 8866463 Review. No abstract available.
Cited by
-
Dispositions of enrofloxacin and its major metabolite ciprofloxacin in Thai swamp buffaloes.J Vet Med Sci. 2016 Mar;78(3):397-403. doi: 10.1292/jvms.15-0464. Epub 2015 Nov 20. J Vet Med Sci. 2016. PMID: 26596287 Free PMC article.
-
Multilocus sequence analysis reveals genetic diversity in Staphylococcus aureus isolate of goat with mastitis persistent after treatment with enrofloxacin.Sci Rep. 2021 Aug 26;11(1):17252. doi: 10.1038/s41598-021-96764-z. Sci Rep. 2021. PMID: 34446803 Free PMC article.
-
Effects of enrofloxacin treatment on the bacterial microbiota of milk from goats with persistent mastitis.Sci Rep. 2020 Mar 10;10(1):4421. doi: 10.1038/s41598-020-61407-2. Sci Rep. 2020. PMID: 32157153 Free PMC article.
-
Use of quercetin in animal feed: effects on the P-gp expression and pharmacokinetics of orally administrated enrofloxacin in chicken.Sci Rep. 2018 Mar 13;8(1):4400. doi: 10.1038/s41598-018-22354-1. Sci Rep. 2018. PMID: 29535328 Free PMC article.
-
Pharmacokinetic-pharmacodynamic integration of enrofloxacin and its metabolite ciprofloxacin in buffalo calves.Vet Med Sci. 2015 Nov 26;1(2):63-71. doi: 10.1002/vms3.10. eCollection 2015 Oct. Vet Med Sci. 2015. PMID: 29067175 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources